Genovior Products - FDF Drugs List 1

Genovior Products - FDF Drugs List 1
Product Description

Azacitidine inj

Bortezomib inj

Docetaxel inj

Doxorubicin inj

Epirubicin inj

Fulvestrant inj

Gemcitabine inj

Irinotecan inj

Oxaliplatin inj

Pemetrexed inj

Octreotide inj

GENOVIOR BIOTECH CORPORATION

  • TW
  • 2016
    On CPHI since
  • 1
    Certificates
  • 100 - 249
    Employees
Company types
CMO/CDMO
Manufacturer/Innovator
Primary activities
Contract Manufacturer
Specifications
  • Supplied from
    Taiwan, China

GENOVIOR BIOTECH CORPORATION

  • TW
  • 2016
    On CPHI since
  • 1
    Certificates
  • 100 - 249
    Employees
Company types
CMO/CDMO
Manufacturer/Innovator
Primary activities
Contract Manufacturer

More Products from GENOVIOR BIOTECH CORPORATION (7)

  • Semaglutide (GLP-1 Drug)

    Product Semaglutide (GLP-1 Drug)

    API < USD 500 per gram, COA available Finished product
  • CDMO Services

    Product CDMO Services

    Genovior is a dedicated CMO/CDMO, focusing on providing clients excellent, efficient, one stop services and solutions, from clinical trials (IND/NDA) to commercialization.

    Our services include:

    1. Process Development
    2. Formulation Development
    3. Analytical Development
    ...
  • CDMO Services - API

    Product CDMO Services - API

    small moleculepeptide
    biologics
  • CDMO Services - FDF drugs

    Product CDMO Services - FDF drugs

    VialsPrefilled Syringe
    Injection Pen 
  • Genovior Products - API

    Product Genovior Products - API

    • Azacitidine (Oncology) • Bortezomib (Oncology) • Fulvestrant (Oncology) • Pemetrexed (Oncology) • Ponatinib (Oncology) • Glucagon (Endocrinology) • Octreotide (Endocrinology) • Teriparatide (Osteoporosis)
  • Genovior Products - FDF Drugs List 2

    Product Genovior Products - FDF Drugs List 2

    Acyclovir inj

    Colistin inj

    Ganciclovir inj

    Teicoplanin inj

    Vancomycin inj

    Levetiracetam inj

    Valproate inj

    ...
  • Interview by Newsweek, time to talk

    Product Interview by Newsweek, time to talk

    Interviewee:Dr. Steve J.P. Hsu (President of Genovior Biotech)

GENOVIOR BIOTECH CORPORATION resources (9)